Posted in Antibodies, Assay Kits, Biology Cells, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, Elisa Kits, Enzymes, Equipments, Exosomes, NATtrol, Panel, PCR, Pcr Kits, Peptides
Improvement of in situ Follicular Activation and Early Development in Cryopreserved Human Ovarian Cortical Tissue by Co-Culturing with Mesenchymal Stem Cells.
Follicle losses and network degeneration are major challenges in the ovarian tissue culture system. Mesenchymal (MSC) stem cells emit the cocktail of growth and cytokines that support adjacent cells and networks. The purpose of this study was to investigate the impact of the human bone marrow (HBM) -MSC, as culture cells, in the development of follicular humans in ovarian cortical tissue (October). For this purpose, the OCT fraction was properly cultured along with HBM-MSC for 8 days and compared to October monoculture. During the cultural period, survival and development of ovarians in October was evaluated using histological observation, gene expression associated with follicular development, and estradiol production.
Furthermore, cell proliferation and apoptosis are assessed. The results showed that there was no significant difference in ovarian follicles which were preserved with normal morphology between the two groups. However, the percentage of follicular development, as well as the expression of follicular development gene, increased significantly in cultural groups compared to monoculture groups. On the other hand, compared to the monoculture group, the culture group showed a significant increase in cell proliferation, indicated by the expression of KI67 gene, and a dramatic decline in the percentage of apoptotic cells, revealed by the Tunel test. These findings indicate that the HBM-MSC co-cultivation with October can increase the activation of follicles and the development of initial follicles in the human ovarian network culture system.
The increase in the efficacy of Vivo from the clinical class of cryopreserved human hepatocytes in mice with acute liver failure.
Clinical clinical hepatocytes of short-term efficacy has been shown; However, some of the main limitations, mainly due to lack of organs, the lack of quality of insulated cells and low cells after transplantation, must be resolved to increase its efficacy in clinical applications. Cellular stress during isolation causes loss of unexpected cell attachment capabilities, which can be exacerbated by cryopreservation and disbursement. In this work, we focus on the use of good manufacturing practices (GMP) solutions compared to standard cryopreservation media, Wisconsin University media, for the purpose of improving the functional quality of cells and its ability to instill in vivo, with the idea of establishing biobank from human hepatocytes Cryopreserved available for use their clinical.
We evaluate not only cell viability but also certain liver function indicators of functional performance of cells such as attachment efficiency, urogenic capabilities, phase and II enzyme enzyme activities and specific adhesion molecular expressions in vitro. In addition, we also assess and compare the efficacy of in vivo from hepatocytes of human hepatocytes in different media in the animal model of acute liver failure. Humatocytes of Cryopreserved Humans in GMP solutions new offers in vitro functionality better and in vivo compared to those who are cryopreserved in standard media. Overall, the results showed that the GMP solution tested newly maintained better liver function and, most importantly, showed better results in Vivo, which could imply an increase in the long-term efficacy when used in patients.
The genetic diagnosis of β-thalassemia preplantation uses short tandem repetition on cryopreserved human blastocythis.
This study aims to evaluate the application of short tandem repetitions (STRS) for the diagnosis of genetic prequlantation (PGD) β-thalassemia. This is a prospective study that appears at the Pregnant Hospital and Liuzhou Child Health. From May to December 2016, eight couples formed from two β-thalassemia operators underwent a procedure and PGD fertilization (IVF) in vitro. All couples and four family members / couples undergo blood testing. Genome amplification of all trophy cell cells is done. PCR products are used for link analysis of 15 strokus. Of the eight couples, 147 embryos were obtained and 86 blastokistas were formed. DNA from 82 Blastokista was successfully reinforced (95.4% amplification efficiency).

Eighty Blastokista obtained a definite diagnosis. Among them, 24 blastokistas were diagnosed as normal, 38 blastokistas were diagnosed as heterozygous for β-thalassemia, and 18 homozygous blastokistas or heterozygous compounds. Two patients received a melting embryo and both had clinical pregnancies. These results indicate that in the PGD settings for β-thalassemia, after several displacement amplifications, the reverse dot hybridization combined with strs can be an effective, accurate, and practical clinical strategy to increase β-thalassemia detection in pairs that are at risk of transferring embryo. These results must be validated in a larger cohort.
Is the 7th day of the 7th culture for fertilizing in vitro from the oocyte of cryopreserved / warm man?
Human embryos are usually cultured to the Blastokyst stage on day 5 or 6 after insemination. However, some embryos grew slowly and reached the Blastokyst stage on Day 7. The level of direct birth. Acceptable birthday has been reported after the 7-blastocista day transfer is produced from the fresh oockey in vitro fertilization (IVF). It is not known whether an extended embryonic culture until the 7th day is needed for more ivf ocyte ivf to get a more transfer blastocist. In this study, 455 oocytes of 57 cycles were warmed, inseminated, and the resulting embryo was cultured by day 7 to test the development after the expanded culture.
Human CellExp? CD38, human recombinant |
P1014-10 |
Biovision |
each |
EUR 248.4 |
Human CellExp? CD38, human recombinant |
P1014-50 |
Biovision |
each |
EUR 574.8 |
Human CellExp? CD45, human recombinant |
P1015-10 |
Biovision |
each |
EUR 301.2 |
Human CellExp? CD45, human recombinant |
P1015-25 |
Biovision |
each |
EUR 548.4 |
Human CellExp? VSIG4, human recombinant |
P1018-10 |
Biovision |
each |
EUR 248.4 |
Human CellExp? VSIG4, human recombinant |
P1018-50 |
Biovision |
each |
EUR 574.8 |
Human CellExp? TrkA, human recombinant |
P1020-10 |
Biovision |
each |
EUR 210 |
Human CellExp? NOV, human recombinant |
P1022-10 |
Biovision |
each |
EUR 235.2 |
Human CellExp? NOV, human recombinant |
P1022-25 |
Biovision |
each |
EUR 352.8 |
Human CellExp? EGFRvIII, human recombinant |
P1082-10 |
Biovision |
each |
EUR 339.6 |
Human CellExp? LOXL2, human recombinant |
P1084-10 |
Biovision |
each |
EUR 183.6 |
Human CellExp? LOXL2, human recombinant |
P1084-50 |
Biovision |
each |
EUR 639.6 |
Human CellExp? CD83, Human recombinant |
P1109-10 |
Biovision |
each |
EUR 157.2 |
Human CellExp? CD83, Human recombinant |
P1109-50 |
Biovision |
each |
EUR 483.6 |
Human CellExp? CD160, human recombinant |
P1110-10 |
Biovision |
each |
EUR 170.4 |
Human CellExp? CD160, human recombinant |
P1110-50 |
Biovision |
each |
EUR 470.4 |
Human CellExp? CNDP1, Human recombinant |
P1125-10 |
Biovision |
each |
EUR 248.4 |
Human CellExp? CNDP1, Human recombinant |
P1125-50 |
Biovision |
each |
EUR 1005.6 |
Human CellExp? VAPB, Human recombinant |
P1135-10 |
Biovision |
each |
EUR 157.2 |
Human CellExp? VAPB, Human recombinant |
P1135-50 |
Biovision |
each |
EUR 444 |
Human CellExp? Transthyretin, Human recombinant |
P1138-20 |
Biovision |
each |
EUR 222 |
Human CellExp? Transthyretin, Human recombinant |
P1138-50 |
Biovision |
each |
EUR 470.4 |
Human CellExp? Sclerostin, human recombinant |
P1145-10 |
Biovision |
each |
EUR 183.6 |
Human CellExp? Sclerostin, human recombinant |
P1145-50 |
Biovision |
each |
EUR 639.6 |
Human CellExp? SLITRK6, human recombinant |
P1146-10 |
Biovision |
each |
EUR 170.4 |
Human CellExp? SLITRK6, human recombinant |
P1146-50 |
Biovision |
each |
EUR 535.2 |
Human CellExp? LILRB2, human recombinant |
P1147-10 |
Biovision |
each |
EUR 157.2 |
Human CellExp? LILRB2, human recombinant |
P1147-50 |
Biovision |
each |
EUR 483.6 |
Human CellExp? ROR1, human recombinant |
P1152-10 |
Biovision |
each |
EUR 170.4 |
Human CellExp? ROR1, human recombinant |
P1152-50 |
Biovision |
each |
EUR 535.2 |
Human CellExp? DLL3, Human Recombinant |
P1165-10 |
Biovision |
each |
EUR 679.2 |
Human CellExp? DLK1, Human Recombinant |
P1166-10 |
Biovision |
each |
EUR 666 |
Human CellExp? PTPRD, Human Recombinant |
P1184-10 |
Biovision |
each |
EUR 183.6 |
Human CellExp? PTPRD, Human Recombinant |
P1184-50 |
Biovision |
each |
EUR 614.4 |
Human CellExp? KRAS, Human Recombinant |
P1198-10 |
Biovision |
each |
EUR 170.4 |
Human CellExp? KRAS, Human Recombinant |
P1198-1000 |
Biovision |
each |
EUR 3184.8 |
Human CellExp? KRAS, Human Recombinant |
P1198-250 |
Biovision |
each |
EUR 1070.4 |
Human CellExp? KRAS, Human Recombinant |
P1198-50 |
Biovision |
each |
EUR 314.4 |
Human CellExp? Hemopexin, Human Recombinant |
P1210-10 |
Biovision |
each |
EUR 235.2 |
Human CellExp? Hemopexin, Human Recombinant |
P1210-50 |
Biovision |
each |
EUR 796.8 |
Human CellExp? ECE1, Human Recombinant |
P1227-10 |
Biovision |
each |
EUR 301.2 |
Human CellExp? ECE1, Human Recombinant |
P1227-50 |
Biovision |
each |
EUR 1214.4 |
Human CellExp? CD8b, Human Recombinant |
P1244-10 |
Biovision |
each |
EUR 288 |
Human CellExp? CD8b, Human Recombinant |
P1244-1000 |
Biovision |
each |
Ask for price |
Human CellExp? CD8b, Human Recombinant |
P1244-250 |
Biovision |
each |
Ask for price |
Human CellExp? CD8b, Human Recombinant |
P1244-50 |
Biovision |
each |
EUR 966 |
Human CellExp? ROR2, Human Recombinant |
P1254-10 |
Biovision |
each |
EUR 274.8 |
Human CellExp? VEGF110, Human Recombinant |
P1258-10 |
Biovision |
each |
EUR 574.8 |
Human CellExp? Prolactin, Human Recombinant |
P1311-10 |
Biovision |
each |
EUR 183.6 |
Human CellExp? Prolactin, Human Recombinant |
P1311-250 |
Biovision |
each |
Ask for price |
Human CellExp? Prolactin, Human Recombinant |
P1311-50 |
Biovision |
each |
EUR 288 |
Human CellExp? Dermatopontin, Human Recombinant |
P1319-10 |
Biovision |
each |
EUR 405.6 |
Human CellExp? sCD14, Human Recombinant |
7122-10 |
Biovision |
each |
EUR 170.4 |
Human CellExp? sCD14, Human Recombinant |
7122-50 |
Biovision |
each |
EUR 430.8 |
Human CellExp? Thrombomodulin, Human Recombinant |
7215-10 |
Biovision |
each |
EUR 288 |
Human CellExp? Thrombomodulin, Human Recombinant |
7215-50 |
Biovision |
each |
EUR 1032 |
Human CellExp? BAFF, human recombinant |
7222-10 |
Biovision |
each |
EUR 307.2 |
Human CellExp? SHH, human recombinant |
7223-10 |
Biovision |
each |
EUR 255.6 |
Human CellExp? EGF, human recombinant |
7228-10 |
Biovision |
each |
EUR 352.8 |
Human CellExp? ADAM12, human recombinant |
7239-10 |
Biovision |
each |
EUR 307.2 |
Human CellExp? DKK3, human recombinant |
7243-50 |
Biovision |
each |
EUR 411.6 |
Human CellExp? SPAM1, human recombinant |
7247-10 |
Biovision |
each |
EUR 470.4 |
Human CellExp? SPAM1, human recombinant |
7247-50 |
Biovision |
each |
EUR 1396.8 |
Human CellExp? UPA, human recombinant |
7248-10 |
Biovision |
each |
EUR 398.4 |
Human CellExp? UPA, human recombinant |
7248-50 |
Biovision |
each |
EUR 1324.8 |
Human CellExp? Furin, human recombinant |
7249-10 |
Biovision |
each |
EUR 548.4 |
Human CellExp? GAD1, human recombinant |
7250-10 |
Biovision |
each |
EUR 379.2 |
Human CellExp? PCSK9, human recombinant |
7265-20 |
Biovision |
each |
EUR 489.6 |
Human CellExp? LIF, human recombinant |
7267-10 |
Biovision |
each |
EUR 464.4 |
Human CellExp? CD36, human recombinant |
7371-10 |
Biovision |
each |
EUR 294 |
Human CellExp? CD36, human recombinant |
7371-50 |
Biovision |
each |
EUR 836.4 |
Human CellExp? CD80, human recombinant |
7383-10 |
Biovision |
each |
EUR 280.8 |
Human CellExp? CD80, human recombinant |
7383-50 |
Biovision |
each |
EUR 810 |
Human CellExp? CD47, human recombinant |
7385-10 |
Biovision |
each |
EUR 333.6 |
Human CellExp? TNFRII, human recombinant |
7394-10 |
Biovision |
each |
EUR 307.2 |
Human CellExp? SERPIND1, human recombinant |
7411-10 |
Biovision |
each |
EUR 346.8 |
Human CellExp? VTCN1, human recombinant |
7412-10 |
Biovision |
each |
EUR 294 |
Human CellExp? VTCN1, human recombinant |
7412-50 |
Biovision |
each |
EUR 836.4 |
Human CellExp? CD23, human recombinant |
7435-10 |
Biovision |
each |
EUR 314.4 |
Human CellExp? CD23, human recombinant |
7435-50 |
Biovision |
each |
EUR 861.6 |
Human CellExp? TIMP1, human recombinant |
7440-10 |
Biovision |
each |
EUR 366 |
Human CellExp? EPHB4, human recombinant |
7451-100 |
Biovision |
each |
EUR 861.6 |
Human CellExp? EPHB4, human recombinant |
7451-20 |
Biovision |
each |
EUR 326.4 |
Human CellExp? TFPI, human recombinant |
7453-10 |
Biovision |
each |
EUR 339.6 |
Human CellExp? CD147, human recombinant |
7455-10 |
Biovision |
each |
EUR 294 |
Human CellExp? CD147, human recombinant |
7455-50 |
Biovision |
each |
EUR 836.4 |
Human CellExp? CD155, human recombinant |
7462-10 |
Biovision |
each |
EUR 294 |
Human CellExp? CD155, human recombinant |
7462-50 |
Biovision |
each |
EUR 836.4 |
Human CellExp? VLDLR, human recombinant |
7464-10 |
Biovision |
each |
EUR 294 |
Human CellExp? VLDLR, human recombinant |
7464-50 |
Biovision |
each |
EUR 836.4 |
Human CellExp? CADM1, human recombinant |
7465-10 |
Biovision |
each |
EUR 294 |
Human CellExp? CADM1, human recombinant |
7465-50 |
Biovision |
each |
EUR 836.4 |
Human CellExp? Transferrin, human recombinant |
7467-100 |
Biovision |
each |
EUR 901.2 |
Human CellExp? Transferrin, human recombinant |
7467-20 |
Biovision |
each |
EUR 333.6 |
Human CellExp? FOLR2, human recombinant |
7471-10 |
Biovision |
each |
EUR 280.8 |
Human CellExp? FOLR2, human recombinant |
7471-50 |
Biovision |
each |
EUR 802.8 |
Human CellExp? LDLR, human recombinant |
7472-10 |
Biovision |
each |
EUR 360 |
Human CellExp? LDLR, human recombinant |
7472-50 |
Biovision |
each |
EUR 992.4 |
Human CellExp? TFPI2, human recombinant |
7481-10 |
Biovision |
each |
EUR 360 |
Human CellExp? RBP4, human recombinant |
7563-10 |
Biovision |
each |
EUR 373.2 |
Human CellExp? RBP4, human recombinant |
7563-50 |
Biovision |
each |
EUR 1038 |
Human CellExp? UNC5B, human recombinant |
7576-10 |
Biovision |
each |
EUR 326.4 |
Human CellExp?CD4, human recombinant |
7834-100 |
Biovision |
each |
EUR 861.6 |
Human CellExp?CD4, human recombinant |
7834-20 |
Biovision |
each |
EUR 320.4 |
Human CellExp? TIGIT, human recombinant |
8015-10 |
Biovision |
each |
EUR 418.8 |
Human CellExp? Azurocidin, human recombinant |
8017-20 |
Biovision |
each |
EUR 320.4 |
Human CellExp? CD163, Human recombinant |
9226-10 |
Biovision |
each |
EUR 366 |
Human CellExp? CD163, Human recombinant |
9226-50 |
Biovision |
each |
EUR 927.6 |
Human CellExp? BTLA, Human recombinant |
9228-10 |
Biovision |
each |
EUR 346.8 |
Human CellExp? BTLA, Human recombinant |
9228-50 |
Biovision |
each |
EUR 882 |
Human CellExp? CD28, Human recombinant |
9237-10 |
Biovision |
each |
EUR 268.8 |
Human CellExp? CD28, Human recombinant |
9237-100 |
Biovision |
each |
EUR 868.8 |
Human CellExp? CD19, Human recombinant |
9246-10 |
Biovision |
each |
EUR 320.4 |
Human CellExp? CD19, Human recombinant |
9246-25 |
Biovision |
each |
EUR 548.4 |
Human CellExp? Progranulin, Human Recombinant |
4738-10 |
Biovision |
each |
EUR 366 |
Human CellExp? Progranulin, Human Recombinant |
4738-100 |
Biovision |
each |
EUR 2727.6 |
Human CellExp? Renin, Human Recombinant |
6300-10 |
Biovision |
each |
EUR 196.8 |
Human CellExp? Renin, Human Recombinant |
6300-100 |
Biovision |
each |
EUR 940.8 |
Human CellExp? Renin, Human Recombinant |
6300-50 |
Biovision |
each |
EUR 601.2 |
Human CellExp? EPO, Human Recombinant |
6447-10 |
Biovision |
each |
EUR 646.8 |
Human CellExp? EPO, Human Recombinant |
6447-50 |
Biovision |
each |
EUR 2017.2 |
Human CellExp? HGF, Human Recombinant |
6456-10 |
Biovision |
each |
EUR 464.4 |
Human CellExp? HGF, Human Recombinant |
6456-50 |
Biovision |
each |
EUR 1677.6 |
Human CellExp? HGH, Human Recombinant |
6457-10 |
Biovision |
each |
EUR 405.6 |
Human CellExp? HGH, Human Recombinant |
6457-50 |
Biovision |
each |
EUR 1455.6 |
Human CellExp? Noggin, Human Recombinant |
6474-10 |
Biovision |
each |
EUR 360 |
Human CellExp? Noggin, Human Recombinant |
6474-50 |
Biovision |
each |
EUR 1286.4 |
Human CellExp? SCF, Human Recombinant |
6478-10 |
Biovision |
each |
EUR 411.6 |
Human CellExp? SCF, Human Recombinant |
6478-50 |
Biovision |
each |
EUR 1599.6 |
Human CellExp? TPO, Human Recombinant |
6483-10 |
Biovision |
each |
EUR 438 |
Human CellExp? TPO, Human Recombinant |
6483-50 |
Biovision |
each |
EUR 2376 |
Human CellExp? CD177, Human Recombinant |
P1410-10 |
Biovision |
each |
EUR 183.6 |
Human CellExp? CD177, Human Recombinant |
P1410-50 |
Biovision |
each |
EUR 470.4 |
Human CellExp? PM20D1, Human Recombinant |
P1430-10 |
Biovision |
each |
EUR 483.6 |
Human CellExp? DLL3, Human Recombinant |
P1463-10 |
Biovision |
each |
EUR 202.8 |
Human CellExp? DLL3, Human Recombinant |
P1463-50 |
Biovision |
each |
EUR 601.2 |
Human CellExp? Properdin, Human Recombinant |
P1470-10 |
Biovision |
each |
EUR 196.8 |
Human CellExp? Properdin, Human Recombinant |
P1470-50 |
Biovision |
each |
EUR 574.8 |
Human CellExp™ TPBG, Human Recombinant |
P1553-10 |
Biovision |
10 µg |
EUR 211.2 |
Human CellExp™ TPBG, Human Recombinant |
P1553-50 |
Biovision |
50 µg |
EUR 576 |
Human CellExp™ PON1, Human Recombinant |
P1556-10 |
Biovision |
10 µg |
EUR 187.2 |
Human CellExp™ PON1, Human Recombinant |
P1556-50 |
Biovision |
50 µg |
EUR 661.2 |
Human, Myostatin Human Recombinant Protein, Plant |
PROTO14793 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: Myostatin Human Recombinant produced in Nicotiana benthamiana plant is a single chain containing 115 amino acids (molecular formula C586H865N165O164S12) and 6-His-tag at the N-terminal having the total molecular mass of 13.2kDa. |
Human, Myostatin Human Recombinant Protein, HEK |
PROTO14793-4 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: Myostatin Human Recombinant produced in HEK cells is a single, glycosylated, polypeptide chain (Asn24-Ser375) containing a total of 360 amino acids, having a calculated molecular mass of 41.1kDa. Myostatin is fused to a 2 aa N-terminal linker and a 6 aa His tag at N-Terminus. |
Human, Thrombin Human Recombinant Protein, HEK |
PROTP00734 |
BosterBio |
Regular: 50ug |
EUR 1135.2 |
Description: Recombinant Human Thrombin produced in HEK cells, having a total molecular weight of 36kDa. ;The Thrombin is purified by proprietary chromatographic techniques. |
Human, Renin Human Recombinant Protein, HEK |
PROTP00797-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: Renin Human Recombinant produced in HEK cells is a single, glycosylated, polypeptide chain (Leu24-Arg406) containing a total of 393 amino acids, having a calculated molecular mass of 43.7kDa and fused to a 10 aa His tag at C-Terminus. |
Human, Renin Human Recombinant Protein, sf9 |
PROTP00797-2 |
BosterBio |
Regular: 5ug |
EUR 380.4 |
Description: REN Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 391 amino acids (24-406) and having a molecular mass of 43.3kDa (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).;REN is fused to 8 amino acid His-Tag at C-terminus and purified by proprietary chromatographic techniques. |
Human, Insulin Human Recombinant Protein, Yeast |
PROTP01308-1 |
BosterBio |
Regular: 10mg |
EUR 380.4 |
Description: Insulin Human Recombinant produced in Yeast is a two chain, glycosylated polypeptide chain containing 51 amino acids and having a molecular mass of 5807 Dalton. Zinc content was found to be 0.4%. Insulin is purified by proprietary chromatographic techniques. |
Human, CD74 Human Recombinant Protein, Sf9 |
PROTP04233-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD74 produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 166 amino acids (73-232a.a.) and having a molecular mass of 19.05kDa (Molecular size on SDS-PAGE will appear at approximately 18-28kDa). CD74 is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human, CD5 Human Recombinant Protein, Sf9 |
PROTP06127-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD5 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 359 amino acids (25-372a.a.) and having a molecular mass of 40kDa (Molecular size on SDS-PAGE will appear at approximately 40-57 kDa). CD5 is expressed with a 6 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human, CD2 Human Recombinant Protein, sf9 |
PROTP06729-2 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD2 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 194 amino acids (25-209a.a.) and having a molecular mass of 22.3kDa (Molecular size on SDS-PAGE will appear at approximately 28-40 kDa).;CD2 is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human, CD14 Human Recombinant Protein, CHO |
PROTP08571 |
BosterBio |
Regular: 50ug |
EUR 380.4 |
Description: The CD14 is produced from human CD14 transfected CHO-cells. Before transfection the complete human CD14-cDNA was amplified by PCR and cloned into expression vector p-POL-DHFR. The myeloid differentiation antigen CD14 acts as the major receptor for bacterial LPS. The dominant form of the recombinant wild type CD14 is the 50-kDa protein containing 335 amino acids and lacks the GPI-Anchor. |
Human, CD7 Human Recombinant Protein, Sf9 |
PROTP09564-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD7 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 164 amino acids (26-180a.a.) and having a molecular mass of 17.5kDa (Molecular size on SDS-PAGE will appear at approximately 18-28kDa). CD7 is expressed with a 6 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human, Pleiotrophin Human Recombinant Protein, HEK |
PROTP13232-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: Pleiotrophin Human Recombinant produced in HEK cells is a non-glycosylated monomer, having a molecular weight of 18kDa.;The Pleiotrophin is purified by proprietary chromatographic techniques. |
Human, CD99 Human Recombinant Protein, Sf9 |
PROTP14209-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD99 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 342 amino acids (23-122a.a.) and having a molecular mass of 37.3kDa (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).;CD99 is expressed with a 239 amino acids hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human, LIF Human Recombinant Protein, Yeast |
PROTP15018-1 |
BosterBio |
Regular: 25ug |
EUR 380.4 |
Description: LIF Human Recombinant produced in yeast is a single, glycosylated polypeptide chain containing 180 amino acids and having a molecular mass of 58.5 kDa. The LIF is purified by proprietary chromatographic techniques. |
Human, CD46 Human Recombinant Protein, Sf9 |
PROTP15529-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD46 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 268 amino acids (35-313 aa) and having a molecular mass of 32.5kDa (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).;CD46 is fused to 6 amino acid His-Tag at C-terminus and purified by proprietary chromatographic techniques. |
Human, Endoglin Human Recombinant Protein, Sf9 |
PROTP17813 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD105 Human Recombinant extracellular domain produced in baculovirus is a homodimeric, glycosylated, Polypeptide containing 586 amino acids and having a molecular mass of 61 kDa but as a result of glycosylation, migrates at 90 kDa under reducing conditions in SDS-PAGE._x000D_ The CD105 is fused to a C-terminal His-tag (6xHis) and purified by proprietary chromatographic techniques. |
Human, CD58 Human Recombinant Protein, Sf9 |
PROTP19256-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD58 produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 196 amino acids (29-215a.a.) and having a molecular mass of 22.5kDa. (Molecular size on SDS-PAGE will appear at approximately 28-40kDa).;CD58 is expressed with a 9 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human, CD27 Human Recombinant Protein, sf9 |
PROTP26842-1 |
BosterBio |
Regular: 5ug |
EUR 380.4 |
Description: CD27 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 413 amino acids (21-191a.a.) and having a molecular mass of 46.4kDa (Molecular size on SDS-PAGE will appear at approximately 28-57kDa).;CD27 is fused with a 239 amino acids hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human, CD34 Human Recombinant Protein, Sf9 |
PROTP28906-2 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD34 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 268 amino acids (32-290a.a.) and having a molecular mass of 28.6kDa (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).;CD34 is fused with a 6 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human, CD68 Human Recombinant Protein, 38kDa |
PROTP34810 |
BosterBio |
Regular: 5ug |
EUR 574.8 |
Description: CD68 Human Recombinant full length expressed in E.coli, shows a 38 kDa band on SDS-PAGE.;CD68 is purified by proprietary chromatographic techniques. |
Human, CD68 Human Recombinant Protein, sf9 |
PROTP34810-2 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD68 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 307 amino acids (22-319) and having a molecular mass of 32.6kDa (Molecular size on SDS-PAGE will appear at approximately 57-70kDa).;CD68 is fused to 6 amino acid His-Tag at C-terminus and purified by proprietary chromatographic techniques. |
Human, CD79B Human Recombinant Protein, Sf9 |
PROTP40259-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD79B Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 140 amino acids (29-159a.a.) and having a molecular mass of 16.3kDa (Molecular size on SDS-PAGE will appear at approximately 18-28 kDa).;CD79B is expressed with a 9 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Human, CD200 Human Recombinant Protein, sf9 |
PROTP41217-1 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
Description: CD200 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 444 amino acids (31-232a.a.) and having a molecular mass of 49.7kDa (Molecular size on SDS-PAGE will appear at approximately 57-70 kDa).;CD200 is expressed with a 242 amino acid hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Fifty-one blastokista of the 16 cycles of being used to examine the embryo Aneuploidies Day 7 Blastokista accounted for 15.6% of the total blastokist. The proportion of the top quality of the blastokist is lower on the 7th day than on day 5 or 6. However, there is no difference observed at the level of blastokyst aneuploid between days 5, 6 and 7. Similar clinical pregnancies, ongoing pregnancy and embryonic implantation rates Obtained after the 7th day of the Blastocyst transfer compared to day 5 or 6 blastocyst transfers. These results indicate that the embryo of the oocyte heating cycle must be cultured until 7 days if they do not reach the Blastokyst stage on the 6th day so that the number of blastokistas that can be used can be increased.